(Q48335810)

10 February 2018

title

A maturation model for midazolam clearance (English)

1 reference

10 February 2018

1 reference

1

Brian J Anderson

1 reference

10 February 2018

author name string

Peter Larsson

series ordinal

2

1 reference

10 February 2018

publication date

1 March 2011

1 reference

10 February 2018

published in

Paediatric Anaesthesia

1 reference

10 February 2018

volume

21

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

302-308

1 reference

10 February 2018

Facilitation of drug evaluation in children by population methods and modelling

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Population clinical pharmacology of children: modelling covariate effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Moral responsibility to attain thorough pediatric drug labeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

The problems in scaling adult drug doses to children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

A mechanistic approach for the scaling of clearance in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Mechanism-based concepts of size and maturity in pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Mechanistic basis of using body size and maturation to predict clearance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

The origin of allometric scaling laws in biology from genomes to ecosystems: towards a quantitative unifying theory of biological structure and organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Scaling for size: some implications for paediatric anaesthesia dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Getting the best from pediatric pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Age terminology during the perinatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

The problem of choosing weights in nonlinear regression analysis of pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Extended least squares nonlinear regression: a possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Modelling approaches to dose estimation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Development of CYP2D6 and CYP3A4 in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Paradoxical effects of midazolam in the very young

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Age is of influence on midazolam requirements in a paediatric intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetics of midazolam in total i.v. anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Midazolam-fentanyl anesthesia for major surgery. Plasma levels of midazolam during prolonged total intravenous anesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Contribution of midazolam and its 1-hydroxy metabolite to preoperative sedation in children: a pharmacokinetic-pharmacodynamic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

A pharmacokinetic study of midazolam in paediatric patients undergoing cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Sedation of children requiring artificial ventilation using an infusion of midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Unconsciousness associated with midazolam and erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Ontogeny of midazolam glucuronidation in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Clinical pharmacology of midazolam in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Human renal function maturation: a quantitative description using weight and postmenstrual age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Ontogeny of dextromethorphan O- and N-demethylation in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Age and size are the major covariates for prediction of levobupivacaine clearance in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Meta-analysis: principles and procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Data sharing for pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Population pharmacokinetic modeling in very premature infants receiving midazolam during mechanical ventilation: midazolam neonatal pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Haemodynamic responses and population pharmacokinetics of midazolam following administration to ventilated, preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetics and metabolism of intravenous midazolam in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetics of midazolam during continuous infusion in critically ill neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetics of midazolam in critically ill neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

The pharmacokinetics of midazolam in paediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetic and pharmacodynamic study of midazolam in children during esophagogastroduodenoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetics of midazolam and alpha-hydroxy-midazolam following rectal and intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2010.03364.X

10.1111/J.1460-9592.2010.03364.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018